Spectral AI Inc. Class A Common Stock Q2 2025 Earnings Recap

MDAI Q2 2025 August 13, 2025

Spectral AI Inc. reported a net loss of $7.9 million for Q2 2025, driven by decreased research revenue and increased warrant liabilities, yet maintained a robust cash position to support future initiatives.

Earnings Per Share Miss

$-0.10 vs $-0.07 est.

-42.9% surprise

Revenue Miss

5065000 vs 5131250 est.

-1.3% surprise

Market Reaction

1-Day -0.71%

5-Day -0.24%

30-Day -13.95%

Key Takeaways

Completed a $15 million debt financing agreement and raised $2.7 million in equity, ending the quarter with over $10 million in cash.
Achieved a significant milestone with the FDA submission for the DeepView System in June 2025, anticipated to strengthen commercial efforts.
Research and development revenue fell to $5.1 million, down from $7.5 million year-over-year, reflecting reduced reimbursements under the BARDA contract.
General and administrative expenses decreased to $4.4 million, from $5.8 million, highlighting ongoing operational efficiencies.
The net loss for the first half of 2025 improved to $5.1 million compared to $6.1 million in the same period last year, indicating deeper cost management efforts.

This summary was generated by AI from the official earnings call transcript and is provided for informational purposes only. It does not constitute financial advice. For the complete transcript and financial data, visit MDAI on AllInvestView.

Next Q3 2025